Search Results - "SUGIYAMA, Yasuyuki"

Optimal policy for environmental goods trade in asymmetric oligopolistic eco-industries by Sugiyama, Yasuyuki, Weng, Yungho, Abe, Kenzo

“…In this paper, we examine the optimal structure of an environmental tax to pollution, a production subsidy to a domestic eco-industry, and an import tariff on…”
Get full text

The Pedigree of Immuno-Oncology - History and Current Status of Immunotherapy against Malignancy by Sugiyama, Yasuyuki

“…Since 1970s immunotherapy had been thought to be one of feasible strategies against malignancy. During that time nonspecific immunotherapy by biological…”
Get more information

Accumulated phosphatidylcholine (16:0/16:1) in human colorectal cancer; possible involvement of LPCAT4 by Kurabe, Nobuya, Hayasaka, Takahiro, Ogawa, Mikako, Masaki, Noritaka, Ide, Yoshimi, Waki, Michihiko, Nakamura, Toshio, Kurachi, Kiyotaka, Kahyo, Tomoaki, Shinmura, Kazuya, Midorikawa, Yutaka, Sugiyama, Yasuyuki, Setou, Mitsutoshi, Sugimura, Haruhiko

“…The identification of cancer biomarkers is critical for target‐linked cancer therapy. The overall level of phosphatidylcholine (PC) is elevated in colorectal…”
Get full text

Prevalence of unmet needs and correlated factors in advanced-stage cancer patients receiving rehabilitation by Hasegawa, Takaaki, Goto, Naoya, Matsumoto, Naoto, Sasaki, Yusuke, Ishiguro, Takashi, Kuzuya, Nanori, Sugiyama, Yasuyuki

“…Purpose Although rehabilitation for patients with cancer is currently being provided throughout all phases of the disease, including the advanced stage, much…”
Get full text

Clinicopathological Features and Prognostic Factors of Adenocarcinoma of the Esophagogastric Junction According to Siewert Classification: Experiences at a Single Institution in Japan by Hosokawa, Yuichi, Kinoshita, Takahiro, Konishi, Masaru, Takahashi, Shinichiro, Gotohda, Naoto, Kato, Yuichiro, Daiko, Hiroyuki, Nishimura, Mitsuyo, Katsumata, Kenji, Sugiyama, Yasuyuki, Kinoshita, Taira

“…Background Treatment strategy for adenocarcinoma of the esophagogastric junction (AEG) remains controversial. The aims of this study are to evaluate results of…”
Get full text

Commissioning of the next-generation LLRF control system for the Rapid Cycling Synchrotron of the Japan Proton Accelerator Research Complex by Tamura, Fumihiko, Sugiyama, Yasuyuki, Yoshii, Masahito, Yamamoto, Masanobu, Okita, Hidefumi, Ohmori, Chihiro, Nomura, Masahiro, Shimada, Taihei, Hasegawa, Katsushi, Hara, Keigo, Furusawa, Masashi

“…The low level rf (LLRF) control system has key roles for the stable acceleration of the high intensity beam. The original LLRF control system for the Rapid…”
Get full text

International recycling firm joint ventures and optimal recycling standards by Sugiyama, Yasuyuki, Koonsed, Patcharin

“…In this paper, we consider a Southern economy consisting of an upstream duopoly market for recycled materials and a downstream perfectly competitive market for…”
Get full text

Network-based analysis for identification of candidate genes for colorectal cancer progression by Tsuji, Shingo, Midorikawa, Yutaka, Seki, Motoaki, Takayama, Tadatoshi, Sugiyama, Yasuyuki, Aburatani, Hiroyuki

“…Although high-throughput biological technologies have been producing a vast amount of multi-omics data regarding cancer genomics and several disease…”
Get full text

Tumor Suppressor miR-22 Determines p53-Dependent Cellular Fate through Post-transcriptional Regulation of p21 by TSUCHIYA, Naoto, IZUMIYA, Masashi, SUGIYAMA, Yasuyuki, ABURATANI, Hiroyuki, HARRIS, Curtis C, NAKAGAMA, Hitoshi, OGATA-KAWATA, Hiroko, OKAMOTO, Koji, FUJIWARA, Yuko, NAKAI, Makiko, OKABE, Atsushi, SCHETTER, Aaron J, BOWMAN, Elise D, MIDORIKAWA, Yutaka

“…Selective activation of p53 target genes in response to various cellular stresses is a critical step in determining the ability to induce cell-cycle arrest or…”
Get full text

Polo‐like kinase 1 (PLK1) is overexpressed in primary colorectal cancers by Takahashi, Takao, Sano, Bun, Nagata, Takayasu, Kato, Hiroki, Sugiyama, Yasuyuki, Kunieda, Katsuyuki, Kimura, Masashi, Okano, Yukio, Saji, Shigetoyo

“…PLK (polo‐like kinase), the human counterpart of polo in Drosophila melanogaster and of CDC5 in Saccharomyces cerevisiae, belongs to a family of…”
Get full text

Prognostic factors of T4 gastric cancer patients undergoing potentially curative resection by Fukuda, Naoto, Sugiyama, Yasuyuki, Wada, Joji

“…AIM：To investigate the prognostic factors of T4 gastric cancer patients without distant metastasis who could undergo potentially curative resection. METHODS：We…”
Get full text

Factors predicting mortality in emergency abdominal surgery in the elderly by Fukuda, Naoto, Wada, Joji, Niki, Michio, Sugiyama, Yasuyuki, Mushiake, Hiroyuki

“…This study aimed to investigate clinical features of abdominal emergency surgery in elderly patients, and to determine factors predicting mortality in these…”
Get full text

Depletion of CD4+CD25+ regulatory T cells enhances interleukin‐2‐induced antitumor immunity in a mouse model of colon adenocarcinoma by Imai, Hisashi, Saio, Masanao, Nonaka, Kenichi, Suwa, Tatsuhiko, Umemura, Naoki, Ouyang, Guan‐Feng, Nakagawa, Jiro, Tomita, Hiroyuki, Osada, Shinji, Sugiyama, Yasuyuki, Adachi, Yosuke, Takami, Tsuyoshi

“…Interleukin 2 (IL)‐2 induces antitumor immunity and clinical responses in melanoma and renal cell carcinoma. However, IL‐2 also increases the number of…”
Get full text

Behavior of Cu nanoparticles ink under reductive calcination for fabrication of Cu conductive film by Ida, Kiyonobu, Tomonari, Masanori, Sugiyama, Yasuyuki, Chujyo, Yuki, Tokunaga, Tomoharu, Yonezawa, Tetsu, Kuroda, Kotaro, Sasaki, Katsuhiro

“…Cu nanoparticle ink was prepared from Cu nanoparticles that were coated with a gelatin layer at an average diameter of 46nm. The Cu nanoparticle ink was…”
Get full text

The Data Acquisition System of the KOTO Experiment and the RCE Platform Technology Upgrade by Su, Stephanie, Ameel, Jon, Beechert, Jacqueline, Campbell, Myron, Gee, Carolyn, Huff, Margaret, Micallef, Jessica, Robinson, Joshua, Rymph, Christopher, Schamis, Hanna, Taylor, Molly, Tecchio, Monica, Whallon, Nikola, Jia Xu, Sugiyama, Yasuyuki, Tajima, Yasuhisa, Bogdan, Mircea, Yau Wah

“…The KOTO experiment at J-PARC, Japan, aims to observe the rare neutral kaon decay mode K L → π 0 νν̅. After the first experimental run in May 2013 at a 24-kW…”
Get full text

The Data Acquisition System for the KOTO Experiment by Sugiyama, Yasuyuki, Jia Xu, Tecchio, Monica, Whallon, Nikola, McFarland, Duncan, Jiasen Ma, Togawa, Manabu, Tajima, Yasuhisa, Bogdan, Mircea, Ameel, Jon, Campbell, Myron, Yau Wai Wah, Comfort, Joseph, Yamanaka, Taku

“…We developed and built a new readout and trigger electronics system, based on a waveform digitization and pipeline readout, for the KOTO experiment at J-PARC,…”
Get full text

Molecular targets for liver cancer therapy: From screening of target genes to clinical trials by Midorikawa, Yutaka, Sugiyama, Yasuyuki, Aburatani, Hiroyuki

“…Cancer arises from the accumulation of genetic alterations, and the inactivation of oncogenes, or recovery of suppressor genes, are promising strategies for…”
Get full text

A phase II clinical study of mFOLFOX6 plus bevacizumab as first-line therapy for Japanese advanced/recurrent colorectal cancer patients by Nishina, Tomohiro, Takano, Yoshinao, Denda, Tadamichi, Yasui, Hisateru, Takeda, Koji, Ura, Takashi, Esaki, Taito, Okuyama, Yusuke, Kondo, Ken, Takahashi, Yasuo, Sugiyama, Yasuyuki, Muro, Kei

“…In Japan, there had been no prospective clinical studies conducted in terms of modified FOLFOX6 + bevacizumab therapy. We performed a post-marketing Phase II…”
Get full text

Multiharmonic vector rf voltage control for wideband cavities driven by vacuum tube amplifiers in a rapid cycling synchrotron by Tamura, Fumihiko, Sugiyama, Yasuyuki, Yoshii, Masahito, Yamamoto, Masanobu, Ohmori, Chihiro, Nomura, Masahiro, Shimada, Taihei, Hasegawa, Katsushi, Hara, Keigo, Furusawa, Masashi

“…Beam loading compensation in the rf cavities is a key for acceleration of high-intensity beams in the 3 GeV rapid cycling synchrotron (RCS) of the Japan Proton…”
Get full text

Multicenter phase II study of FOLFIRI plus bevacizumab after discontinuation of oxaliplatin-based regimen for advanced or recurrent colorectal cancer (CR0802) by Suenaga, Mitsukuni, Nishina, Tomohiro, Mizunuma, Nobuyuki, Yasui, Hisateru, Ura, Takashi, Denda, Tadamichi, Ikeda, Junichi, Esaki, Taito, Nishisaki, Hogara, Takano, Yoshinao, Sugiyama, Yasuyuki, Muro, Kei

“…To investigate the efficacy and safety of FOLFIRI plus bevacizumab regimen with irinotecan (180 mg/m(2)) in patients with advanced or recurrent colorectal…”
Get full text